Table 2.
Univariate and multivariate overall survival (OS) analysis of CXCR2 in AML patients.
parameter | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Gender(male/female) | 0.937 | 0.586–1.497 | 0.785 | 1.183 | 0.705–1.987 | 0.522 |
Age(<60 y/>=60y) | 2.268 | 1.415–3.636 | 0.00066** | 2.153 | 1.264–3.665 | 0.0047* |
WBC(<2G/L/>=2G/L) | 1.245 | 0.779–1.991 | 0.359 | 1.028 | 0.579–1.824 | 0.924 |
Blast (%) | 1.005 | 0.996–1.015 | 0.261 | 1.004 | 0.994–1.015 | 0.390 |
Risk stratification (low/median/high) |
1.822 | 1.274–2.606 | 0.0010* | 1.540 | 1.029–2.305 | 0.036* |
FLT3 (mut/wt) | 1.392 | 0.840–2.305 | 0.199 | 1.286 | 0.719–2.297 | 0.396 |
IDH1(mut/wt) | 0.832 | 0.446–1.549 | 0.561 | 0.771 | 0.392–1.517 | 0.451 |
CXCR2 (high/low) | 1.226 | 1.067–1.408 | 0.0039* | 1.185 | 1.005–1.398 | 0.043* |
*p > 0.001, **P < 0.001 (P < 0.05)